Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000950135-06-000807
Filing Date
2006-02-14
Accepted
2006-02-14 11:24:21
Documents
1
Group Members
ALAN G. SPOON ("SPOON")JONATHAN A. FLINT ("FLINT")POLARIS VENTURE MANAGEMENT CO. III, L.L.C. ("POLARIS III")POLARIS VENTURE PARTNERS ENTREPENEURS FUND III L.P.POLARIS VENTURE PARTNERS FOUNDERS FUND III, L.P.TERRANCE G. MCGUIRE ("MCGUIRE")

Document Format Files

Seq Description Document Type Size
1 POLARIS VENTURE SC 13G/A b59174apsc13gza.txt SC 13G/A 36207
  Complete submission text file 0000950135-06-000807.txt   38603
Mailing Address 1000 WINTER STREET SUITE 3350 WALTHAM MA 02451
Business Address 1000 WINTER STREET SUITE 3350 WALLTHAM MA 02451-1215 7812900770
POLARIS VENTURE PARTNERS III LP (Filed by) CIK: 0001104639 (see all company filings)

EIN.: 043497143
Type: SC 13G/A

Mailing Address 300 THIRD STREET CAMBRIDGE MA 02142
Business Address 300 THIRD STREET CAMBRIDGE MA 02142 (617) 551-8200
ALNYLAM PHARMACEUTICALS, INC. (Subject) CIK: 0001178670 (see all company filings)

EIN.: 770602661 | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-79884 | Film No.: 06609130
SIC: 2834 Pharmaceutical Preparations